![](/imgs/covers/au_cover.jpg)
|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 10, No. 1, 2000, pp. 10-15
|
Bioline Code: au00006
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Australasian Biotechnology (backfiles), Vol. 10, No. 1, 2000, pp. 10-15
en |
BIOTECH BUSINESS
Abstract
FLORIGENE TAKEOVER
MEDICA ATTRACTS INVESTMENT
BIOTA IN PROFIT
NOVOGEN CUTS ITS LOSSES
LISTING TO SUPPORT ALZHEIMER'S DRUG
PROGEN CAPITAL RAISING
BRESAGEN SALES SUCCESS
GRADIPORE LOSS
BIONOMICS LISTS
AMRAD SELLS DRUG DISCOVERY BUSINESS
GENE SHEARS FIGHTS OFF PATENT CHALLENGE
A VACCINE FOR GLANDULAR FEVER
BIOTECH BUYOUT
NEW R&D PROJECT FOR AQUACAROTENE
AMRAD DEAL
FDA CLEARANCE
TECHNICO INVESTMENT
FLINDERS LICENSES DNA SAMPLING TECHNOLOGY
AIMS SIGNS SUNSCREEN DEAL
NEW FOOD TREATMENT PROJECT
AUTOGEN PURCHASE
PEPTECH AND BIOTECH AGREE TO MERGE
AMRAD Biotech becomes SILENUS
TRIAL PROGRESS FOR CARDIAC DRUG
New Test for Rapid Blood Clot Diagnosis
|
|
© Copyright 2000 - Australasian Biotechnology Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16
|
|